American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) . Washington, DC: APA.
Anderson, I. M. (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. Journal of Affective Disorders, 58, 19–36.
Barnes, N. M. & Sharp, T. (1999) A review of central 5-HT receptors and their function. Neuropharmacology, 38, 1083–1152.
Cleare, A. J., Murray, R. M., Sherwood, R. A., et al (1998) Abnormal 5-HT1D receptor function in major depression: a neuropharmacological challenge study using sumatriptan. Psychological Medicine, 28, 295–300.
Cowen, P. J. & Charig, E. M. (1987) Neuroendocrine responses to intravenous tryptophan in major depression. Archives of General Psychiatry, 44, 958–966.
Cowen, P. J., Power, A. C., Ware, C. J., et al (1994) 5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. British Journal of Psychiatry, 164, 372–379.
Delgado, P. L., Miller, H. L., Salomon, R. M., et al (1999) Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biological Psychiatry, 46, 212–220.
Dinan, T. G. (1994) Glucocorticoids and the genesis of depressive illness. A psychobiological model. British Journal of Psychiatry, 164, 365–371.
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.
Johnson, K. W., Schaus, J. M., Durkin, M. M., et al (1997) 5-HT1E receptor agonists inhibit neurogenic dural inflammation in guinea pigs. Neuroreport, 8, 2237–2240.
Lesch, K. P. (1992) 5-HT1A receptor responsivity in anxiety disorders and depression. Progress in Neuropsychopharmacology and Biological Psychiatry, 15, 723–733.
Maura, G., Marcoli, M., Tortarolo, M., et al (1998) Glutamate release in human cerebral cortex and its modulation by 5-hydroxytryptamine acting at 5-HT|1D receptors. British Journal of Pharmacology, 123, 45–50.
Quested, D. J., Sargent, P. A. & Cowen, P. J. (1997) SSRI treatment decreased prolactin and hyperthermic responses to mCPP. Psychopharmacology, 133, 305–308.
Sargent, P., Williamson, D. J., Pearson, G., et al (1997) Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity. Psychopharmacology, 132, 296–302.
Skare, S. S., Dysken, M. W. & Billington, C. J. (1994) A review of GHRH stimulation test in psychiatry. Biological Psychiatry, 36, 249–265.
Smith, K. A., Williams, C. & Cowen, P. J. (2000) Impaired regulation of brain serotonin function during dieting in women recovered from depression. British Journal of Psychiatry, 176, 72–75.
Whale, R. & Cowen, P. J. (1998) Probing the function of 5-HT1B/1D receptors in psychiatric patients. CNS Spectrums, 3, 40–45.
Bhagwagar, Z. & Cowen, P. J. (1999) Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors?
Psychopharmacology, 145, 223–226.
Yatham, L. N., Athanasios, P. Z., Lam, R. W., et al (1997) Sumatriptan-induced growth hormone release in patients with major depression, mania and normal controls. Neuropsychopharmacology, 17, 258–263.